Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Eucalyptus Globulus Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of Eucalyptus-specific allergies. It belongs to the class of pollen allergenic extracts used in immunotherapy and skin testing.
Name
Eucalyptus Globulus Pollen
Raw Name
EUCALYPTUS GLOBULUS POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
8
Variant Count
9
Last Verified
February 17, 2026
About Eucalyptus Globulus Pollen
Eucalyptus Globulus Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of Eucalyptus-specific allergies. It belongs to the class of pollen allergenic extracts used in immunotherapy and skin testing.
Detailed information about Eucalyptus Globulus Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Eucalyptus Globulus Pollen.
Eucalyptus Globulus Pollen, derived from the Blue Gum tree (Eucalyptus globulus), is a specialized biological product classified as a Non-Standardized Pollen Allergenic Extract [EPC]. This substance is primarily utilized by allergists and immunologists for the diagnosis and management of Type I hypersensitivity reactions (allergic reactions) specifically triggered by the inhalation of Eucalyptus pollen. Within the pharmacological landscape, this extract belongs to a broader class of drugs known as allergenic extracts, which are designed to either identify a patient's specific allergic triggers through diagnostic testing or to desensitize the patient's immune system through a process known as allergen immunotherapy (AIT).
The Eucalyptus globulus tree is native to Australia but has been widely naturalized in Mediterranean climates, including parts of California, South Africa, and Southern Europe. Consequently, its pollen has become a significant aeroallergen in these regions. The FDA has historically regulated these extracts as biologics, ensuring that the manufacturing process maintains a consistent concentration of the source material, though 'non-standardized' implies that the extract is not measured by its biological potency in humans, but rather by its weight-to-volume (W/V) ratio or Protein Nitrogen Units (PNU).
The mechanism of action for Eucalyptus Globulus Pollen depends on whether it is being used for diagnostic purposes or therapeutic immunotherapy. At the molecular level, the extract contains various proteins and glycoproteins that act as antigens.
In diagnostic skin testing (percutaneous or intradermal), the extract is introduced into the skin. If the patient has pre-existing IgE (Immunoglobulin E) antibodies specific to Eucalyptus globulus pollen, these antibodies, which are bound to the surface of mast cells in the skin, will recognize the pollen proteins. This recognition triggers the cross-linking of IgE receptors, leading to mast cell degranulation. This process releases inflammatory mediators such as histamine, leukotrienes, and prostaglandins, resulting in a localized 'wheal and flare' reaction (a raised bump and redness). This reaction confirms the patient's sensitivity to the allergen.
In therapeutic immunotherapy (commonly known as 'allergy shots'), the extract is administered in gradually increasing doses. This process, known as hyposensitization, aims to shift the immune system's response from a Th2-dominated allergic response to a Th1-dominated or regulatory T-cell (Treg) response. Over time, this results in the production of 'blocking antibodies' (IgG4), a decrease in specific IgE levels, and a reduction in the recruitment of inflammatory cells like eosinophils and basophils to the respiratory mucosa. Essentially, it 'trains' the immune system to tolerate the pollen rather than overreacting to it.
Traditional pharmacokinetic studies (absorption, distribution, metabolism, and excretion) are not typically performed for allergenic extracts like Eucalyptus Globulus Pollen, as they are biological mixtures rather than single chemical entities. However, their behavior in the body can be described through immunological principles.
Eucalyptus Globulus Pollen extract is FDA-approved for the following clinical indications:
Eucalyptus Globulus Pollen extract is typically available in the following forms:
> Important: Only your healthcare provider can determine if Eucalyptus Globulus Pollen is right for your specific condition. Immunotherapy should only be administered under the supervision of a physician prepared to treat anaphylaxis.
Dosage for Eucalyptus Globulus Pollen is highly individualized and must be determined by an allergy specialist based on the patient's sensitivity levels. There is no 'standard' dose because this is a non-standardized extract.
Eucalyptus Globulus Pollen extracts are used in children, but the safety and efficacy have not been established in very young children (typically under age 5). Dosing principles for older children are generally similar to adult dosing, though the starting dose may be even more conservative depending on the child's allergic history and the severity of their asthma.
No specific dosage adjustments are required for patients with renal impairment, as the extract is not known to be nephrotoxic. However, the patient's overall health should be stable before receiving an injection.
No dosage adjustments are necessary for hepatic impairment. The metabolic processing of these proteins does not rely on primary hepatic CYP450 pathways.
Elderly patients should be evaluated for cardiovascular stability. If an elderly patient is taking beta-blockers for hypertension or heart disease, immunotherapy may be contraindicated due to the difficulty of treating anaphylaxis in these patients.
If a dose is missed during the build-up phase, the next dose may need to be reduced to ensure safety. If a maintenance dose is missed for several weeks, the physician will likely 'back up' the dosage to a lower concentration and rebuild. Never attempt to 'double up' on doses to make up for a missed appointment.
An 'overdose' in the context of allergenic extracts usually refers to an injection of a concentration that is too high for the patient's current tolerance level. Signs of overdose include immediate systemic allergic reactions: hives, swelling, wheezing, or a drop in blood pressure. Emergency treatment with epinephrine is required immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Most patients receiving Eucalyptus Globulus Pollen immunotherapy will experience some form of local reaction. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Eucalyptus Globulus Pollen and call your doctor immediately if you experience any of these.
There are no known long-term 'toxic' effects of Eucalyptus Globulus Pollen extracts. Unlike many medications, allergenic extracts do not damage the liver, kidneys, or heart over time. The primary long-term risk is the development of a new sensitivity or the persistence of local skin irritation at the site of repeated injections.
Allergenic extracts, including Eucalyptus Globulus Pollen, carry a significant warning regarding the risk of severe systemic reactions.
Report any unusual symptoms to your healthcare provider.
Eucalyptus Globulus Pollen extract is a potent biological product. It is intended for use only by physicians experienced in the diagnosis and treatment of allergic diseases. Because of the risk of severe systemic reactions, including anaphylaxis, patients must be observed for a minimum of 30 minutes following any injection.
No FDA black box warnings for Eucalyptus Globulus Pollen specifically, but it falls under the general class warning for all non-standardized allergenic extracts. This class warning emphasizes that these products can cause anaphylaxis and should be administered only by those trained in emergency resuscitation and the use of epinephrine.
Generally, Eucalyptus Globulus Pollen does not affect the ability to drive. However, if a patient experiences a systemic reaction or feels lightheaded/dizzy after an injection, they should not operate a vehicle until they are fully cleared by a medical professional.
While there is no direct chemical interaction between alcohol and Eucalyptus Globulus Pollen, alcohol consumption can cause vasodilation (widening of blood vessels), which may theoretically increase the rate of allergen absorption and the severity of an allergic reaction. It is advisable to avoid alcohol for several hours before and after an injection.
Immunotherapy is typically discontinued if the patient experiences a life-threatening reaction or if there is no significant improvement in symptoms after 1-2 years of maintenance therapy. There is no 'withdrawal' syndrome associated with stopping allergy shots, but the patient's allergy symptoms will likely return over time.
> Important: Discuss all your medical conditions with your healthcare provider before starting Eucalyptus Globulus Pollen.
There are no known direct food interactions with Eucalyptus Globulus Pollen. However, patients with 'Oral Allergy Syndrome' may find that certain foods cross-react with tree pollens, though this is more common with birch or ragweed than with Eucalyptus.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Patients allergic to Eucalyptus Globulus Pollen may show cross-sensitivity to other members of the Myrtaceae family, which includes plants like Myrtle, Allspice, and Cloves. If you have had a severe reaction to any of these, inform your allergist.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Eucalyptus Globulus Pollen.
Pregnancy Category C: There are no adequate and well-controlled studies of Eucalyptus Globulus Pollen extract in pregnant women.
It is not known whether the components of Eucalyptus Globulus Pollen extract are excreted in human milk. Because these are large proteins that are likely broken down in the mother's tissues, the risk to a nursing infant is considered negligible. Breastfeeding is generally not a contraindication for continuing immunotherapy.
Patients over age 65 should be screened carefully for cardiovascular disease. The elderly are more likely to be taking medications (like beta-blockers or ACE inhibitors) that complicate the safety of immunotherapy. Furthermore, the ability of the aging immune system to respond to desensitization (immunosenescence) may be reduced.
No specific studies have been conducted in patients with renal impairment. However, since the allergens are proteins that are enzymatically degraded, renal function is not a primary factor in the safety or efficacy of the extract.
No dosage adjustments are required for patients with liver disease. The liver does not play a significant role in the clearance of injected allergenic proteins.
> Important: Special populations require individualized medical assessment.
Eucalyptus Globulus Pollen extract works by modulating the immune system's response to specific allergens. In an allergic individual, exposure to Eucalyptus pollen causes Th2 cells to stimulate B-cells to produce IgE. These IgE antibodies bind to mast cells. When the extract is injected during immunotherapy, it induces several changes:
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous) |
| Protein Binding | Localized to IgE/IgG |
| Half-life | Days (immunological effect years) |
| Tmax | 30-60 minutes (absorption) |
| Metabolism | Proteolytic degradation |
| Excretion | Renal (as peptides) |
Eucalyptus Globulus Pollen is classified as a Non-Standardized Pollen Allergenic Extract. It is part of the therapeutic category of 'Allergenics' and the sub-category of 'Tree Pollen Extracts.'
Common questions about Eucalyptus Globulus Pollen
Eucalyptus Globulus Pollen extract is primarily used for the diagnosis and treatment of allergies related to the Blue Gum Eucalyptus tree. In a clinical setting, doctors use it for skin prick testing to confirm if a patient's respiratory symptoms, such as sneezing or wheezing, are caused by this specific pollen. It is also used in allergen immunotherapy, commonly known as allergy shots, to desensitize the immune system over time. By injecting small, increasing amounts of the pollen extract, the body learns to tolerate the allergen, eventually reducing the severity of allergic rhinitis and asthma symptoms. This treatment is particularly useful for patients who do not find enough relief from standard over-the-counter allergy medications.
The most frequent side effects of Eucalyptus Globulus Pollen injections are localized reactions at the site of the shot. Patients often experience redness, swelling, and itching in the arm where the injection was given, which usually subsides within a day. Some people may also notice a small, hard lump at the injection site that can last for a few days. Occasionally, patients might feel slightly fatigued or experience a temporary increase in their typical allergy symptoms, like a runny nose or itchy eyes, shortly after the treatment. While these common side effects are bothersome, they are generally not dangerous and can often be managed with ice packs or antihistamines.
There is no known direct chemical interaction between alcohol and Eucalyptus Globulus Pollen extract; however, healthcare providers generally advise caution. Alcohol can cause your blood vessels to dilate, which might theoretically speed up the absorption of the allergen into your bloodstream, potentially increasing the risk or severity of an allergic reaction. Furthermore, alcohol can mask the early symptoms of a systemic reaction, such as feeling flushed or lightheaded, making it harder for you to recognize an emergency. It is best to avoid consuming alcohol for at least several hours before and after your allergy injection. Always follow the specific safety guidelines provided by your allergist regarding lifestyle choices during immunotherapy.
Eucalyptus Globulus Pollen is classified as FDA Pregnancy Category C, meaning there is limited data on its safety in pregnant women. Most allergists recommend against starting the 'build-up' phase of immunotherapy during pregnancy because the risk of a severe allergic reaction (anaphylaxis) could harm the fetus by reducing oxygen levels. However, if a patient is already on a stable maintenance dose and becomes pregnant, many doctors allow the treatment to continue since the risk of a reaction is significantly lower at that stage. The decision to continue or stop treatment is highly individualized and must be discussed with both an allergist and an obstetrician. The primary goal is always to balance the mother's respiratory health with the safety of the developing baby.
The timeline for seeing results from Eucalyptus Globulus Pollen immunotherapy is gradual and requires patience. Most patients do not notice a significant decrease in their allergy symptoms until they reach the 'maintenance phase,' which typically takes 3 to 6 months of weekly injections. Significant clinical improvement is usually observed after the first full year of consistent treatment. For the best long-term results, a full course of immunotherapy usually lasts between 3 and 5 years. If a patient does not see any improvement after one year of maintenance therapy, the doctor may re-evaluate the treatment plan. It is important to remember that allergy shots are a long-term disease-modifying therapy, not an immediate fix like an antihistamine pill.
Yes, you can stop taking Eucalyptus Globulus Pollen injections suddenly without experiencing physical withdrawal symptoms, as it is not an addictive substance. However, stopping treatment prematurely, especially before completing the recommended 3-to-5-year course, usually means that your allergy symptoms will eventually return. The 'training' your immune system received may not be permanent if the course is cut short. If you need to stop treatment due to side effects, financial reasons, or a change in location, you should discuss this with your allergist. They can help you transition to other forms of allergy management or provide records so you can continue your shots with a different provider.
If you miss a scheduled dose of Eucalyptus Globulus Pollen, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to make up for the missed dose by taking more the next time. The safety of immunotherapy depends on a strict schedule; if too much time passes between injections, your immune system's tolerance may decrease. Depending on how many weeks you have missed, your doctor may need to reduce your next dose and then gradually build it back up to your previous level. Missing multiple doses frequently can significantly delay your progress and reduce the overall effectiveness of the treatment.
There is no clinical evidence to suggest that Eucalyptus Globulus Pollen allergenic extracts cause weight gain. The extract consists of natural proteins and stabilizers that do not interfere with metabolism, appetite, or fat storage. Unlike systemic corticosteroids (like prednisone), which are sometimes used to treat severe allergies and are known to cause weight gain, allergenic extracts work specifically on the immune system's response to pollen. If you experience weight changes while on immunotherapy, it is likely due to other factors, such as lifestyle changes or other medications you may be taking. You should discuss any unexpected weight changes with your primary care physician.
Eucalyptus Globulus Pollen can be taken alongside most common medications, but there are some critical exceptions. You must inform your doctor if you are taking beta-blockers (often used for blood pressure or heart conditions), as these can make it very difficult to treat a severe allergic reaction if one occurs. Other medications, like ACE inhibitors and certain antidepressants (MAOIs or TCAs), may also increase the risk or severity of side effects. While you can continue taking your regular allergy medications like Claritin or Flonase during immunotherapy, you must stop taking antihistamines for several days before a skin test. Always provide your allergist with a complete list of all prescriptions, over-the-counter drugs, and supplements you use.
The concept of a 'generic' drug does not apply to allergenic extracts in the same way it does to chemical tablets. Eucalyptus Globulus Pollen is a biological product, and while several different manufacturers may produce an extract of the same pollen, they are not considered identical or interchangeable. Each manufacturer's extract may have slight differences in protein concentration and potency. Therefore, if you switch providers or if your clinic changes its supplier, your doctor will usually restart your dosing at a lower concentration to ensure safety. These products are typically referred to by their source name (Eucalyptus Globulus) rather than a brand or generic name.